Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer.

Lin, Mao

Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer. [electronic resource] - Immunology letters 11 2017 - 10-15 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1879-0542

10.1016/j.imlet.2017.09.004 doi


Adult
Aged
Antigens, Neoplasm--metabolism
Biomarkers, Tumor--metabolism
Carcinoembryonic Antigen--metabolism
Carcinoma, Non-Small-Cell Lung--diagnosis
Female
Humans
Immunotherapy, Adoptive--methods
Keratin-18--metabolism
Killer Cells, Natural--immunology
Lung Neoplasms--diagnosis
Lymphocyte Count
Male
Middle Aged
Neoplasm Proteins--metabolism
Neoplasm Staging
Neoplastic Cells, Circulating--pathology
Prognosis
Transplantation, Homologous
Treatment Outcome